HELIUM EVOLUTION INC (HEVI.CA) Fundamental Analysis & Valuation

TSX-V:HEVI • CA42328K1021

Current stock price

0.17 CAD
-0.02 (-10.53%)
Last:

This HEVI.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. HEVI.CA Profitability Analysis

1.1 Basic Checks

  • HEVI had negative earnings in the past year.
  • HEVI had a negative operating cash flow in the past year.
HEVI.CA Yearly Net Income VS EBIT VS OCF VS FCFHEVI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

  • With a Return On Assets value of -15.25%, HEVI perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
  • With a Return On Equity value of -28.72%, HEVI perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
Industry RankSector Rank
ROA -15.25%
ROE -28.72%
ROIC N/A
ROA(3y)-31.68%
ROA(5y)N/A
ROE(3y)-33.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HEVI.CA Yearly ROA, ROE, ROICHEVI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for HEVI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HEVI.CA Yearly Profit, Operating, Gross MarginsHEVI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

2

2. HEVI.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for HEVI remains at a similar level compared to 1 year ago.
  • HEVI has a better debt/assets ratio than last year.
HEVI.CA Yearly Shares OutstandingHEVI.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M
HEVI.CA Yearly Total Debt VS Total AssetsHEVI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

  • HEVI has an Altman-Z score of 0.09. This is a bad value and indicates that HEVI is not financially healthy and even has some risk of bankruptcy.
  • HEVI has a Altman-Z score (0.09) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.00 indicates that HEVI is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.00, HEVI belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.09
ROIC/WACCN/A
WACCN/A
HEVI.CA Yearly LT Debt VS Equity VS FCFHEVI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

  • HEVI has a Current Ratio of 0.90. This is a bad value and indicates that HEVI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HEVI's Current ratio of 0.90 is on the low side compared to the rest of the industry. HEVI is outperformed by 62.96% of its industry peers.
  • HEVI has a Quick Ratio of 0.90. This is a bad value and indicates that HEVI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • HEVI has a Quick ratio of 0.90. This is comparable to the rest of the industry: HEVI outperforms 48.15% of its industry peers.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.9
HEVI.CA Yearly Current Assets VS Current LiabilitesHEVI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M 8M 10M

0

3. HEVI.CA Growth Analysis

3.1 Past

  • HEVI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.09%.
EPS 1Y (TTM)-22.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-652.63%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • HEVI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.77% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-88.84%
EPS Next 2Y2.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HEVI.CA Yearly EPS VS EstimatesHEVI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0 -0.01 -0.01 -0.02 -0.02

0

4. HEVI.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for HEVI. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HEVI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HEVI.CA Price Earnings VS Forward Price EarningsHEVI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HEVI.CA Per share dataHEVI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 -0.04 0.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.77%
EPS Next 3YN/A

0

5. HEVI.CA Dividend Analysis

5.1 Amount

  • HEVI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

HEVI.CA Fundamentals: All Metrics, Ratios and Statistics

HELIUM EVOLUTION INC

TSX-V:HEVI (3/16/2026, 7:00:00 PM)

0.17

-0.02 (-10.53%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-25
Earnings (Next)04-20
Inst Owners6.28%
Inst Owner ChangeN/A
Ins Owners8.76%
Ins Owner ChangeN/A
Market Cap27.71M
Revenue(TTM)N/A
Net Income(TTM)-3.35M
Analysts84
Price Target0.51 (200%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)42.86%
PT rev (3m)42.86%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.38
P/tB 2.38
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -15.25%
ROE -28.72%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-31.68%
ROA(5y)N/A
ROE(3y)-33.11%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 41261.9%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.9
Quick Ratio 0.9
Altman-Z 0.09
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)9063.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-652.63%
EPS Next Y-88.84%
EPS Next 2Y2.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-31.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-255.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-219.15%
OCF growth 3YN/A
OCF growth 5YN/A

HELIUM EVOLUTION INC / HEVI.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HELIUM EVOLUTION INC?

ChartMill assigns a fundamental rating of 1 / 10 to HEVI.CA.


What is the valuation status of HELIUM EVOLUTION INC (HEVI.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to HELIUM EVOLUTION INC (HEVI.CA). This can be considered as Overvalued.


Can you provide the profitability details for HELIUM EVOLUTION INC?

HELIUM EVOLUTION INC (HEVI.CA) has a profitability rating of 1 / 10.


How financially healthy is HELIUM EVOLUTION INC?

The financial health rating of HELIUM EVOLUTION INC (HEVI.CA) is 2 / 10.